The novel curcumin analogue AKT-100 targets both mutant p53 and STAT3 in gynecologic cancer cells is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01CA99908–22 (KL)
National Institutes of Health
Grant: P50CA264793 (KL)
National Institutes of Health
Grant: P01CA872735 (KL)
University of New Mexico Comprehensive Cancer Center
Grant: P30CA118100
Grant: CDMRP CA210610 (KL)
Grant: CDMRP CA2220729 (KL)
NIGMS NIH HHS
Grant: K12 GM088021
Fields of Study
Keywords